Statistics

Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial70

File Visits

Downloads
36218-371.pdf29

Select a period of time:

Number of views in the range

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial46

Number of downloads in the range

Downloads
36218-371.pdf7

Views

Views
March 202518
April 202510
May 20250
June 20250
July 202517
August 20251
September 20250
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • March 2025
    0
  • April 2025
    2
  • May 2025
    3
  • June 2025
    0
  • July 2025
    1
  • August 2025
    1
  • September 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore18
Hong Kong10
United States8
Brazil7
Barbados1
Ireland1
Mexico1
 

Top countries by downloads

Downloads
Hong Kong2
United States2
 

Top cities views

Views
Hong Kong10
Bridgetown1
Campinas1
Campo Largo1
Dublin1
Meriden1
Pekin1
Providence1
Recife1
Rio Claro1
 

Top cities by downloads

Downloads
Hong Kong2